Loading market data...
Latest Top News
Show more
Windlas Biotech Announces Share Buyback At Premium Price
Windlas Biotech Ltd has set its buyback price at ₹1,000 per equity share, with approval granted for a buyback worth up to ₹470 million. The move underscores the company’s confidence in its financial position and aims to enhance shareholder value through capital allocation.
Stay Ahead – Explore Now! India’s Protein Paradox: Largest Tur Producer Yet Reliant On Global Supply






